UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007648
Receipt No. R000009019
Scientific Title A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer
Date of disclosure of the study information 2012/04/02
Last modified on 2016/05/11 10:13:04

No. Disposal Last modified on Item of update
1 Insert 2012/04/02 23:16:27
2 Update 2013/04/03 12:18:39 Recruitment status
3 Update 2013/05/23 13:07:30 Institute
Email1
4 Update 2016/05/11 10:10:42 Basic design
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
5 Update 2016/05/11 10:13:04 Email
Name of primary sponsor
Institute
Organization
Organization


Contact us.